hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Pfizer Rapamune Lawsuit: Pharma Giant's Subsidiary Accused Of Targeting 'High-Risk' Black Patients For Unapproved Use Of Drug [USA]

Author: Marcus Baram, Huffington Post, Published on: 25 May 2010

In a stunning whistleblower lawsuit, the world's largest pharmaceutical company is being sued over the dangerous practice of illegally promoting a kidney transplant drug for unapproved uses -- and targeting African-Americans, even though they are at high risk of complications...The suit claims: "Wyeth [part of Pfizer] trained and encouraged its sales representatives to market Rapamune for uses outside those listed on the [Federal Drug Administration]-approved label and to misrepresent and withhold clinical information regarding the safety and efficacy of Rapamune. As a result of Wyeth's wrongdoing, patients were put at risk of serious physical and financial harm..." Pfizer [said] "...We are very confident that the current promotional practices surrounding this product are fully compliant with all legal requirements..."

Read the full post here

Related companies: Pfizer Wyeth (part of Pfizer)